Partnering in your passion to save more lives
You deserve a partner as passionate about saving lives and improving outcomes as you are. We're here for you with product training, educational resources, and rescue insights you won't get anywhere else.
Help me find product education and resources by
E-learning platform
Set your staff up for success with our intuitive courses designed for caregivers of all kinds. Learn to use ZOLL devices, data management software, and more.
Insights & Expertise
Get insights and tips for emergency rescue and critical care, straight from our experts:
- Rescue guidelines and best practices
- Educational articles
- Relevant news
Instructional Videos & Resources
You’ll have access to a wide range of informational resources and data monitoring that complements our innovative suite of solutions:
- Instructional videos
- FAQs
- ZOLL® Data Systems resources
- Cardiac patient monitoring info
Make the most of your products
ALSO OF INTEREST
News & Insights
ZOLL Announces Closing of Acquisition of Select Vyaire Ventilator Product Lines
ZOLL, an Asahi Kasei company that manufactures medical devices and related software solutions, announced today that it successfully completed its previously announced acquisition of certain assets of Vyaire Medical’s ventilator business.
ZOLL AED Plus Received Approval for AEDs Under the EU Medical Device Regulation (MDR) Certification
ZOLL, an Asahi Kasei company that manufactures medical devices and related software solutions, announced today that the ZOLL AED Plus® defibrillator is approved under the European Union (EU) Medical Device Regulation 2017/745, commonly referred to as EU MDR. The ZOLL AED 3® received MDR approval in January 2024
Studies Show Significant Unmet Need in Severe Heart Attack Patients and Cost-Effectiveness of SSO2 Therapy
ZOLL, an Asahi Kasei company that manufactures medical devices and related software solutions, announced today the results of two important studies evaluating the economic burden of heart failure resulting from severe heart attack and the long-term cost-effectiveness of SuperSaturated Oxygen (SSO2) Therapy for heart attack treatment.